−£712k
vs Aug 2024Active13572461Private limited companyLondon
NWPHARMATECH LTD
Significant control: Daud Gutseriev (25–50%), Filipp Korentsvit (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Nwpharmatech Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NWPHARMATECH LTD is an active private limited company (company number 13572461) incorporated on 18 August 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 31 August 2025, showing net assets of −£712k and cash of £7,513, with 3 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 71% on the prior period (−£417k).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Daud Gutseriev
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Filipp Korentsvit
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 August 20215 yrs ago
- Next accounts due
- 31 May 2027in 220 days
- Confirmation statement due
- 1 September 2027in 313 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£7,513
+9%vs Aug 2024Not disclosed
3
No changevs Aug 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | −£712k | £7,513 | £3,281 | — | — | — | 3 |
| 31 August 2024 | −£417k | £6,918 | £4,617 | — | — | — | 3 |
Cash per employee£2,504Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-711,823 at 31 August 2025
- Net assets down 25% or more on the prior period-70.6% vs prior period
- Incorporated five or more years agoIncorporated 18 August 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 313 days
- Next accounts duein 220 days
- Accounts period endNet liabilities £712k · abridged accounts
- Accounts period endNet liabilities £417k · abridged accounts
- Incorporated
08
Similar companies in London
- CONCERT BIO LTDLondon · inc. Aug 2021
- VECTOR BIOSCIENCE CAMBRIDGE LTDLondon · inc. Aug 2021
- TWIST BIOSCIENCE UK LTDLondon · inc. Aug 2021
- PROPRIA NANORX LIMITEDLondon · inc. Aug 2021
- KORA BIOWORKS LTDLondon · inc. Aug 2021
- PROMATIX BIOSCIENCES LTDLondon · inc. Aug 2021
All companies incorporated on 18 August 2021 · in Aug 2021.
09
Reminders for NWPHARMATECH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.